Dados B3 › Watcher
Watcher for ONCO3: events of ONCOCLÍNICAS DO BRASIL SERVIÇOS MÉDICOS S.A.
15 event(s) recorded for ONCO3, newest first. Each is a fact with both numbers and the filing that revealed it.
Type: all · Profit or loss · Net margin changed band · Net debt/EBITDA changed band · Restated financial statements · Confidence flag changed colour
| Public on | Type | Fact |
|---|---|---|
| 2025-05-15 | Profit or loss | Profit turned into loss in 1Q2025: net margin from 0.2% in 3Q2024 to -8.8% in 1Q2025.ITR 1T2025, recebida pela CVM em 15/05/2025 |
| 2025-03-28 | Profit or loss | Profit turned into loss in 2024: net margin from 5.7% in 2023 to -11.5% in 2024.DFP 2024, recebida pela CVM em 28/03/2025 |
| 2025-03-28 | Net debt/EBITDA changed band | Net debt/EBITDA went from 3.7x in 2023 to 17.4x in 2024.DFP 2024, recebida pela CVM em 28/03/2025 |
| 2024-05-13 | Net margin changed band | Net margin went from 10.7% in 3Q2023 to 1.3% in 1Q2024.ITR 1T2024, recebida pela CVM em 13/05/2024 |
| 2024-03-27 | Net margin changed band | Net margin went from 2.8% in 2022 to 5.7% in 2023.DFP 2023, recebida pela CVM em 27/03/2024 |
| 2024-03-27 | Confidence flag changed colour | The data confidence flag went from yellow to green with the 2023 statements: none of the previous year's reasons applies any more.DFP 2023, recebida pela CVM em 27/03/2024 |
| 2023-11-13 | Net margin changed band | Net margin went from 2.6% in 2Q2023 to 10.7% in 3Q2023.ITR 3T2023, recebida pela CVM em 13/11/2023 |
| 2023-03-28 | Profit or loss | Loss turned into profit in 2022: net margin from -0.8% in 2021 to 2.8% in 2022.DFP 2022, recebida pela CVM em 28/03/2023 |
| 2023-03-28 | Net debt/EBITDA changed band | Net debt/EBITDA went from 1.4x in 2021 to 3.7x in 2022.DFP 2022, recebida pela CVM em 28/03/2023 |
| 2022-11-10 | Profit or loss | Loss turned into profit in 3Q2022: net margin from -2.7% in 2Q2022 to 4.9% in 3Q2022.ITR 3T2022, recebida pela CVM em 10/11/2022 |
| 2022-05-16 | Profit or loss | Profit turned into loss in 1Q2022: net margin from 22.2% in 3Q2021 to -1.9% in 1Q2022.ITR 1T2022, recebida pela CVM em 16/05/2022 |
| 2022-03-29 | Restated financial statements | 2020 statements restated in the 2021 annual filing: 2 accounts changed by 5% or more; the largest, net operating cash flow (DFC_MI 6.01), went from R$ 97.6 m to R$ 185.6 m.DFP 2021, recebida pela CVM em 29/03/2022, contra a DFP 2020 |
| 2022-03-29 | Net debt/EBITDA changed band | Net debt/EBITDA went from 6.7x in 2020 to 1.4x in 2021.DFP 2021, recebida pela CVM em 29/03/2022 |
| 2021-11-16 | Profit or loss | Loss turned into profit in 3Q2021: net margin from -31.6% in 2Q2021 to 22.2% in 3Q2021.ITR 3T2021, recebida pela CVM em 16/11/2021 |
| 2021-08-16 | Profit or loss | Profit turned into loss in 2Q2021: net margin from 1.1% in 1Q2021 to -31.6% in 2Q2021.ITR 2T2021, recebida pela CVM em 16/08/2021 |
ONCO3 — company page · all events · JSON. Descriptive, not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 05:21 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 05:21 UTC. If this does not match /saude, you are reading a cached copy.